SEC Form 4 · accession 0001127602-16-035487
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Farkas
Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 4, 2016 · 5:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 4, 2016 | P | 332 | $42.1829 | A | 4,064 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The purchase reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 2/27/15.
- F2The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $42.18 to $42.26. Full information regarding the number of shares purchased at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.